Business and Job Creation
Want a thriving economy? The Goldwater Institute knows that best business climate is one where low taxes and minimal regulation benefit all employers – not one where subsidies and special tax breaks offer an advantage to a chosen few. When a government agency can decide which businesses to favor, it opens the door for the misguided pursuit of investment fads or, at worst, the potential for corruption and abuse. Our research offers sound policies for government, and we’re not afraid to fight when we see bad ideas that put taxpayers at risk.
- Press Releases
- In the News
- Amicus Briefs
- OpEds & Blogs
Of Statistics and StrawmenPosted on May 07, 2012 | Type: Blog | Author: Byron Schlomach
Blogger Mike McClellan criticizes the Goldwater Institute and me specifically for our estimate that the 1-cent sales tax rate increase would cost Arizonans 14,000 to 20,000 jobs. He cites the increase in the number of jobs in the state over the last two years and recent predictions that job growth will pick up as evidence of how wrong we were. There’s just one problem with McClellan’s thesis; it has no basis.
AUDIO: Reviving Economic Liberties - A Conversation with Clint BolickPosted on May 07, 2012 | Type: Audio
On the Liberty Law Talk podcast, host Richard Reinsch talks with Clint Bolick, Vice President of Litigation at the Goldwater Institute, about his book Death Grip: Loosening the Law’s Stranglehold over Economic Liberty. Bolick, of course, is no stranger to litigating constitutional claims for economic liberties and property rights, among other achievements.
How to Make the Sun Shine on Solar EnergyPosted on April 25, 2012 | Type: Blog | Author: Stephen Slivinski
Recent news from the solar industry includes headlines about Germany cutting solar subsidies and Arizona-based First Solar laying off 30 percent of its employees.
A Pound of Cure: How Academic Detailing Could Limit Access to PharmaceuticalsPosted on March 27, 2012 | Type: Policy Report | Author: Byron Schlomach
Pharmaceutical sales are coming under criticism based on what appear to be legitimate but rare abuses of pharmaceutical salespeople promising more from a drug than they should and doctors allowing themselves to be pressured into prescribing. Unfortunately, these isolated incidents are being held up as evidence of the need for vast new government intrusion and regulation of the pharmaceutical industry’s marketing practices. While certainly well intentioned, these efforts are likely to negatively affect doctors and patients.
Little-Known Policy in President's Health Care Plan Could Limit Access To PharmaceuticalsPosted on March 26, 2012 | Type: Press Release
New Goldwater Institute Analysis Shines Light On “Academic Detailing”